REGN Competitors & Alternatives
Compare Regeneron Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
REGN
Main Stock$834.04
Tradestie Score
34
Market Cap
$63.59B
P/E Ratio
19.7
Revenue Growth
0.2%
Analyst Upside
-0.1%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GILD
Gilead Sciences Inc
|
$146.12
|
$137.92B | - | 34 | Compare |
|
VRTX
Vertex Pharmaceuticals Inc
|
$548.05
|
$103.64B | 30.8 | 30 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$236.22
|
$60.38B | 42.2 | 42 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$1039.78
|
$46.96B | 39.5 | 43 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$374.47
|
$36.81B | 66.2 | 27 | Compare |
|
INSM
Insmed, Inc.
|
$125.77
|
$31.13B | - | 41 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$116.57
|
$24.57B | - | 41 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$216.78
|
$22.61B | 39.4 | 42 | Compare |
|
GMAB
Genmab A/S ADS
|
$33.45
|
$19.56B | 26.9 | 32 | Compare |
|
INCY
Incyte Genomics Inc
|
$127.81
|
$16.93B | 16.4 | 41 | Compare |
More REGN Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry